Autolus Therapeutics PLC (AUTL)
4.00
+0.32
(+8.70%)
USD |
NASDAQ |
May 01, 16:00
4.16
+0.16
(+4.00%)
Pre-Market: 09:09
Autolus Therapeutics Cash and Short Term Investments (Quarterly): 239.57M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 239.57M |
| September 30, 2023 | 256.42M |
| June 30, 2023 | 307.50M |
| March 31, 2023 | 343.03M |
| December 31, 2022 | 382.44M |
| September 30, 2022 | 163.05M |
| June 30, 2022 | 216.44M |
| March 31, 2022 | 268.56M |
| December 31, 2021 | 310.34M |
| September 30, 2021 | 173.06M |
| June 30, 2021 | 216.35M |
| Date | Value |
|---|---|
| March 31, 2021 | 239.01M |
| December 31, 2020 | 153.30M |
| September 30, 2020 | 177.70M |
| June 30, 2020 | 212.04M |
| March 31, 2020 | 243.31M |
| December 31, 2019 | 210.64M |
| September 30, 2019 | 229.37M |
| June 30, 2019 | 266.19M |
| March 31, 2019 | 187.73M |
| March 31, 2018 | 120.67M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
153.30M
Minimum
Dec 2020
382.44M
Maximum
Dec 2022
242.54M
Average
239.01M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 146.94M |
| Biodexa Pharmaceuticals Plc | 7.606M |
| NuCana PLC | 21.94M |
| TC BioPharm (Holdings) PLC | 3.137M |
| DBV Technologies SA | 141.37M |